Study of Serum Metabonomics and Formula-Pattern Correspondence in Coronary Heart Disease Patients Diagnosed as Phlegm or Blood Stasis Pattern Based on Ultra Performance Liquid Chromatography Mass Spectrometry

被引:13
作者
Lu Xiao-yan [1 ]
Xu Hao [2 ]
Zhao Tie [1 ]
Li Geng [1 ]
机构
[1] China Japan Friendship Hosp, Dept Integrat Cardiol, Beijing 100029, Peoples R China
[2] China Acad Chinese Med Sci, Xiyuan Hosp, Cardiovasc Dis Ctr, Beijing 100091, Peoples R China
基金
中国国家自然科学基金;
关键词
ultra performance liquid chromatography mass spectrometry; metabonomics; phlegm/stasis pattern in coronary heart disease; disease-pattern combination; formula-pattern correspondence;
D O I
10.1007/s11655-018-2564-7
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objectives: To study the characteristics of serum metabonomics in coronary heart disease (CHD) patients diagnosed as phlegm or blood stasis pattern and explore effects of formula-pattern correspondence treatment. Methods: A total of 102 stable CHD patients were enrolled and divided into phlegm group (P group, n=52) and blood stasis group (BS group, n=50) according to pattern identifification. Gualou Xiebai Banxia Decoction ( , GXBD) and Xuefu Zhuyu Decoction ( , XZD) were used as drug interventions. Relevant indicators of metabonomics were observed by ultra performance liquid chromatography mass spectrometry (UPLC-MS) and pattern recognition. Results: Levels of amino acids and phosphatidylethanolamine (PE) in the CHD group were much higher than those in healthy control group, while the levels of unsaturated fatty acids, sphingosine, Lyso, phosphatidylcholine (PC) were signifificantly lower (P<0.01). Most of the differential metabolites between the CHD and the healthy groups were also common metabolites of phlegm and blood stasis. 7(Z), 10(Z)-hexadecadienoic acid and DPA were decreased in the P group and increased in the BS group. According to the quantity of retraced metabolites, improvement in metabonomics by formula-pattern correspondence was superior to that without correspondence in the BS group. Based on the varieties of metabolites, GXBD could improve the levels of docosapentaenoic acid (DPA), sphingomyelin (SM) (d34:1), and L-Lactic acid and XZD could ameliorate the levels of sphingosine and Vit E in the P group. In the BS group, GXBD could improve vitamin E level and XZD could make improvements in the levels of octadecanoic acid, phosphoglycerol, and SM (d34: 1). Conclusions: Phlegm and blood stasis in CHD patients present specifific differential metabolites, and share common metabolites. Remarkable differences have been displayed in pathological properties and severity of phlegm and blood stasis. Patients with phlegm are more likely to have lipid metabolism disorders. However, in patients with blood stasis, problems mainly lie in glucose, protein and fat metabolism and the injury of vascular cell membrane is relatively severe. The metabolic disorder is more complicated in blood stasis pattern than that in phlegm pattern. Compared with non-correspondence, improvement of differential metabolites is more comprehensive and targeted in formula-pattern correspondence with a better effect.
引用
收藏
页码:905 / 911
页数:7
相关论文
共 22 条
  • [21] Comparative metabolomics analysis on invigorating blood circulation for herb pair Gui-Hong by ultra-high-performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry and pattern recognition approach
    Li, Shujiao
    Lin, Hang
    Tang, Yuping
    Li, Weixia
    Shen, Juan
    Kai, Jun
    Yue, Shijun
    Shang, Guanxiong
    Zhu, Zhenhua
    Shang, Erxin
    Zhang, Changbin
    Zhang, Li
    Yan, Hui
    Liu, Pei
    Duan, Jin-ao
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2015, 107 : 456 - 463
  • [22] Effect of ergosta-4,6,8(14),22-tetraen-3-one (ergone) on adenine-induced chronic renal failure rat: A serum metabonomic study based on ultra performance liquid chromatography/high-sensitivity mass spectrometry coupled with MassLynx i-FIT algorithm
    Zhao, Ying-Yong
    Cheng, Xian-Long
    Cui, Ji-Hong
    Yan, Xing-Rong
    Wei, Feng
    Bai, Xu
    Lin, Rui-Chao
    CLINICA CHIMICA ACTA, 2012, 413 (19-20) : 1438 - 1445